Home » Stocks » American Bio Medica

American Bio Medica Corp. (ABMC)

Stock Price: $0.350 USD -0.120 (-25.53%)
Updated Aug 10, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 12.58M
Revenue (ttm) 3.46M
Net Income (ttm) -766,000
Shares Out 35.95M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $0.350
Previous Close $0.470
Change ($) -0.120
Change (%) -25.53%
Day's Open 0.460
Day's Range 0.305 - 0.489
Day's Volume 955,214
52-Week Range 0.055 - 1.260

More Stats

Market Cap 12.58M
Enterprise Value 13.55M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 35.95M
Float 22.24M
EPS (basic) -0.02
EPS (diluted) -0.02
FCF / Share 0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 3.47%
Payout Ratio n/a
Shares Short 5,863
Short Ratio 0.09
Short % of Float n/a
Beta -0.70
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 28.80
PS Ratio 3.64
PB Ratio n/a
Revenue 3.46M
Operating Income -690,000
Net Income -766,000
Free Cash Flow 437,000
Net Cash -963,000
Net Cash / Share -0.03
Gross Margin 34.21%
Operating Margin -19.94%
Profit Margin -22.10%
FCF Margin 12.63%
ROA -16.78%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.350
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-5.6%-21.2%-12.39%-11.21%-13.29%-18.09%-4.81%0.77%-11.03%-
Gross Profit1.
Operating Income-0.59-0.76-0.31-0.26-0.01-0.22-1.13-0.93-0.15-0.53
Net Income-0.68-1.03-0.55-0.35-0.33-0.49-0.79-1.11-0.35-0.75
Shares Outstanding32.5330.1229.2127.4625.6823.3422.2721.8321.7421.74
Earnings Per Share-0.02-0.03-0.02-0.01-0.01-0.02-0.04-0.05-0.02-0.03
Operating Cash Flow0.06-
Capital Expenditures---0.04--0.01-0.04-0.01-0.01-0.17-0.07
Free Cash Flow0.06-
Cash & Equivalents0.
Total Debt1.571.541.321.471.812.172.341.852.002.23
Net Cash / Debt-1.57-1.42-1.29-1.31-1.65-1.82-1.69-1.76-1.91-2.19
Book Value-0.79-0.150.621.030.960.971.341.362.372.66
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name American Bio Medica Corp.
Country United States
Employees 42
CEO Melissa A. Waterhouse

Stock Information

Ticker Symbol ABMC
Stock Exchange US OTC
Unique Identifier OTCMKTS: ABMC
IPO Date December 24, 1997


American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. American Bio Medica Corporation serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.